Mild haemostatic problems associated with congenital heterozygous alpha 2-antiplasmin deficiency
- PMID: 3363537
Mild haemostatic problems associated with congenital heterozygous alpha 2-antiplasmin deficiency
Abstract
A Dutch family, of which 13 members are heterozygotes, deficient for alpha 2-antiplasmin (alpha 2-AP) is reported. Clinical studies showed that 2 heterozygotes had a mild bleeding tendency, which presented as bleeding episodes after tooth extraction and after surgery and, in one patient, also as excessive menstruation. Laboratory investigations revealed an alpha 2-AP activity of 62% (51-71) (median and range) and an antigen level of 60% (60-66). The plasminogen binding as well as the fibrin binding properties of alpha 2-AP were normal. Plasminogen concentrations were significantly higher in the heterozygotes compared to the other family members. However, free plasminogen not bound to histidine-rich glycoprotein was not significantly different between these two groups. We propose that in this family the deficiency of alpha 2-AP is due to a decreased synthesis of a normal alpha 2-AP molecule. This present study brings the frequency of heterozygous alpha 2-AP deficient patients with a bleeding tendency to 13 out of 59 heterozygotes reported in the literature.
Similar articles
-
alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.J Clin Invest. 1987 Nov;80(5):1391-400. doi: 10.1172/JCI113217. J Clin Invest. 1987. PMID: 2445779 Free PMC article.
-
Alpha 2-antiplasmin: functional characterization and metabolism in a heterozygote deficient patient.Thromb Haemost. 1986 Jun 30;55(3):375-8. Thromb Haemost. 1986. PMID: 3750266
-
[Hemorrhagic syndrome and isolated alpha 2-antiplasmin deficiency. Apropos of a case].Pathol Biol (Paris). 1997 Jun;45(6):483-6. Pathol Biol (Paris). 1997. PMID: 9309264 French.
-
Haemostatic management of intraoral bleeding in patients with congenital deficiency of alpha2-plasmin inhibitor or plasminogen activator inhibitor-1.Haemophilia. 2004 Sep;10(5):669-74. doi: 10.1111/j.1365-2516.2004.00914.x. Haemophilia. 2004. PMID: 15357795 Review.
-
Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.Haemophilia. 2008 Nov;14(6):1250-4. doi: 10.1111/j.1365-2516.2008.01766.x. Haemophilia. 2008. PMID: 19141165 Review.
Cited by
-
Clinical disorders of fibrinolysis: a critical review.Blut. 1989 Jul;59(1):1-14. doi: 10.1007/BF00320240. Blut. 1989. PMID: 2526671 Review.
-
Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause.J Thromb Haemost. 2019 Sep;17(9):1478-1488. doi: 10.1111/jth.14529. Epub 2019 Jul 15. J Thromb Haemost. 2019. PMID: 31177606 Free PMC article.
-
Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause.Ann Hematol. 2017 Mar;96(3):489-495. doi: 10.1007/s00277-016-2893-6. Epub 2016 Dec 26. Ann Hematol. 2017. PMID: 28018998 Free PMC article.
-
Enhanced thrombin and plasmin generation profiles in alpha-2-antiplasmin-deficient patients: Data from the Rare Bleeding disorders in the Netherlands study.Res Pract Thromb Haemost. 2024 Oct 23;8(7):102604. doi: 10.1016/j.rpth.2024.102604. eCollection 2024 Oct. Res Pract Thromb Haemost. 2024. PMID: 39628652 Free PMC article.
-
Perioperative Management of Single Lung Transplantation for a Chronic Obstructive Lung Disease Patient with Congenital Alpha2-Plasmin Inhibitor Deficiency.Surg Case Rep. 2025;11(1):25-0230. doi: 10.70352/scrj.cr.25-0230. Epub 2025 Jun 25. Surg Case Rep. 2025. PMID: 40589561 Free PMC article.